Federal Appeals Court Dismisses Cancer Patients’ Case To Use Psilocybin Under Right-To-Try Laws
A lawsuit filed by a physician and his cancer patients against the DEA for denying access to psilocybin therapy was rejected by the Court of Appeals.
The panel of judges determined that the agency is not at fault because it does not have the authority to waive the Controlled Substances Act.
